{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:57:20Z","timestamp":1780509440121,"version":"3.54.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071414"],"award-info":[{"award-number":["82071414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171253"],"award-info":[{"award-number":["82171253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Foundation of Guangzho"},{"name":"National Science Foundation of Guangdong Province of Chia"},{"name":"Guangdong Medical Science and Technology Research Foundation Projec"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Retinal thickness is related to Parkinson\u2019s disease (PD), but its association with the severity of PD is still unclear. We conducted a Mendelian randomized (MR) study to explore the association between retinal thickness and PD. For the two-sample MR analysis, the summary statistics obtained from genome-wide association studies on the thickness of Retinal nerve fiber layer (RNFL) and ganglion cell inner plexiform layer (GCIPL) were employed as exposure, while the summary statistics associated with PD were used as the outcome. The primary approach utilized was inverse variance weighted. To correct for multiple testing, the false discovery rate (FDR) was employed. For sensitivity analysis, an array of robust MR methods was utilized. We found genetically predicted significant association between reduced RNFL thickness and a reduced risk of constipation in PD (odds ratio [OR]\u2009=\u20090.854, 95% confidence interval [CI] (0.782, 0.933), <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, FDR-corrected <jats:italic>P<\/jats:italic>\u2009=\u20090.018). Genetically predicted reduced RNFL thickness was associated with a reduced Unified Parkinson\u2019s Disease Rating Scale total score (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u22120.042, 95% CI (\u22120.079, 0.005), <jats:italic>P<\/jats:italic>\u2009=\u20090.025), and reduced GCIPL thickness was associated with a lower risk of constipation (OR\u2009=\u20090.901, 95% CI (0.821, 0.988), <jats:italic>P<\/jats:italic>\u2009=\u20090.027) but a higher risk of depression (OR\u2009=\u20091.103, 95% CI (1.016, 1.198), <jats:italic>P<\/jats:italic>\u2009=\u20090.020), insomnia (OR\u2009=\u20091.090, 95% CI (1.013, 1.172), <jats:italic>P<\/jats:italic>\u2009=\u20090.021), and rapid eye movement sleep behaviour disorder (RBD) (OR\u2009=\u20091.198, 95% CI (1.061, 1.352), <jats:italic>P<\/jats:italic>\u2009=\u20090.003). In conclusion, we identify an association between retinal thickness and non-motor symptoms (constipation, depression, insomnia and RBD) in PD, highlighting the potential of retinal thickness as a biomarker for PD nonmotor symptoms.<\/jats:p>","DOI":"10.1038\/s41531-023-00611-z","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T14:03:10Z","timestamp":1702476190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Mendelian randomization reveals association between retinal thickness and non-motor symptoms of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Hang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-5741","authenticated-orcid":false,"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-7573","authenticated-orcid":false,"given":"Chin-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-4980","authenticated-orcid":false,"given":"Bin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9928-4805","authenticated-orcid":false,"given":"Eng-King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-6540","authenticated-orcid":false,"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"611_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S. & Bloem, B. R. The emerging evidence of the Parkinson pandemic. J. Parkinson\u2019s Dis. 8, S3\u2013s8 (2018).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"611_CR2","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","volume":"144","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options. Brain 144, 2571\u20132593 (2021).","journal-title":"Brain"},{"key":"611_CR3","first-page":"101615","volume":"52","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson\u2019s disease dementia: An observational study. EClin. Med. 52, 101615 (2022).","journal-title":"EClin. Med."},{"key":"611_CR4","doi-asserted-by":"publisher","first-page":"eabq1141","DOI":"10.1126\/sciadv.abq1141","volume":"9","author":"Q Wang","year":"2023","unstructured":"Wang, Q., Zheng, J., Pettersson, S., Reynolds, R. & Tan, E. K. The link between neuroinflammation and the neurovascular unit in synucleinopathies. Sci. Adv. 9, eabq1141 (2023).","journal-title":"Sci. Adv."},{"key":"611_CR5","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"611_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainresbull.2020.02.001","volume":"157","author":"K Jayaramayya","year":"2020","unstructured":"Jayaramayya, K. et al. Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson\u2019s disease (PD)\u2014a road to discovery? Brain Res. Bull. 157, 169\u2013179 (2020).","journal-title":"Brain Res. Bull."},{"key":"611_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jcp.30932","volume":"238","author":"A Elangovan","year":"2023","unstructured":"Elangovan, A. et al. miRNA in Parkinson\u2019s disease: from pathogenesis to theranostic approaches. J. Cell Physiol. 238, 329\u2013354 (2023).","journal-title":"J. Cell Physiol."},{"key":"611_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.14336\/AD.2022.0514","volume":"14","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. QEEG signatures are associated with nonmotor dysfunctions in Parkinson\u2019s disease and a typical Parkinsonism: an integrative analysis. Aging Dis. 14, 204\u2013218 (2023).","journal-title":"Aging Dis."},{"key":"611_CR9","doi-asserted-by":"publisher","unstructured":"Xie, Z. et al. Healthy human fecal microbiota transplantation into mice attenuates MPTP-induced neurotoxicity via AMPK\/SOD2 pathway. Aging Dis. https:\/\/doi.org\/10.14336\/ad.2023.0309 (2023).","DOI":"10.14336\/ad.2023.0309"},{"key":"611_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., Chaudhuri, K. R. & Jenner, P. Non-motor features of Parkinson disease. Nat. Rev. Neurosci. 18, 435\u2013450 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"611_CR11","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/mds.23368","volume":"25","author":"H Li","year":"2010","unstructured":"Li, H. et al. Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson\u2019s disease. Mov. Disord. 25, 2740\u20132746 (2010).","journal-title":"Mov. Disord."},{"key":"611_CR12","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","volume":"139","author":"RS Weil","year":"2016","unstructured":"Weil, R. S. et al. Visual dysfunction in Parkinson\u2019s disease. Brain 139, 2827\u20132843 (2016).","journal-title":"Brain"},{"key":"611_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s13760-020-01274-w","volume":"120","author":"S Mohana Devi","year":"2020","unstructured":"Mohana Devi, S., Mahalaxmi, I., Aswathy, N. P., Dhivya, V. & Balachandar, V. Does retina play a role in Parkinson\u2019s Disease? Acta. Neurol. Belg. 120, 257\u2013265 (2020).","journal-title":"Acta. Neurol. Belg."},{"key":"611_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/archneur.59.8.1249","volume":"59","author":"NJ Diederich","year":"2002","unstructured":"Diederich, N. J., Raman, R., Leurgans, S. & Goetz, C. G. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch. Neurol. 59, 1249\u20131252 (2002).","journal-title":"Arch. Neurol."},{"key":"611_CR15","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1212\/01.wnl.0000191565.11065.11","volume":"65","author":"EY Uc","year":"2005","unstructured":"Uc, E. Y. et al. Visual dysfunction in Parkinson disease without dementia. Neurology 65, 1907\u20131913 (2005).","journal-title":"Neurology"},{"key":"611_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/mds.28182","volume":"35","author":"AG Hamedani","year":"2020","unstructured":"Hamedani, A. G., Abraham, D. S., Maguire, M. G. & Willis, A. W. Visual impairment is more common in Parkinson\u2019s disease and is a risk factor for poor health outcomes. Mov. Disord. 35, 1542\u20131549 (2020).","journal-title":"Mov. Disord."},{"key":"611_CR17","doi-asserted-by":"publisher","first-page":"e0195983","DOI":"10.1371\/journal.pone.0195983","volume":"13","author":"M Sainohira","year":"2018","unstructured":"Sainohira, M. et al. Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa. PLoS One 13, e0195983 (2018).","journal-title":"PLoS One"},{"key":"611_CR18","doi-asserted-by":"publisher","first-page":"e009658","DOI":"10.1136\/bmjopen-2015-009658","volume":"6","author":"V Polo","year":"2016","unstructured":"Polo, V. et al. Visual dysfunction and its correlation with retinal changes in patients with Parkinson\u2019s disease: an observational cross-sectional study. BMJ Open 6, e009658 (2016).","journal-title":"BMJ Open"},{"key":"611_CR19","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27728","volume":"34","author":"A Murueta-Goyena","year":"2019","unstructured":"Murueta-Goyena, A. et al. Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases. Mov. Disord. 34, 1315\u20131324 (2019).","journal-title":"Mov. Disord."},{"key":"611_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.04.023","volume":"64","author":"A Chrysou","year":"2019","unstructured":"Chrysou, A., Jansonius, N. M. & van Laar, T. Retinal layers in Parkinson\u2019s disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinson\u2019s Relat. Disord. 64, 40\u201349 (2019).","journal-title":"Parkinson\u2019s Relat. Disord."},{"key":"611_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ene.14613","volume":"28","author":"WC Zhou","year":"2021","unstructured":"Zhou, W. C., Tao, J. X. & Li, J. Optical coherence tomography measurements as potential imaging biomarkers for Parkinson\u2019s disease: a systematic review and meta-analysis. Eur. J. Neurol. 28, 763\u2013774 (2021).","journal-title":"Eur. J. Neurol."},{"key":"611_CR22","doi-asserted-by":"publisher","unstructured":"Subramaniam, M. D. et al. Retinal changes in Parkinson\u2019s disease: a non-invasive biomarker for early diagnosis. Cell Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s10571-023-01419-4 (2023).","DOI":"10.1007\/s10571-023-01419-4"},{"key":"611_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41531-022-00325-8","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. The macular inner plexiform layer thickness as an early diagnostic indicator for Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 8, 63 (2022).","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"611_CR24","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1212\/WNL.0000000000006157","volume":"91","author":"J Ahn","year":"2018","unstructured":"Ahn, J. et al. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease. Neurology 91, e1003\u2013e1012 (2018).","journal-title":"Neurology"},{"key":"611_CR25","doi-asserted-by":"publisher","first-page":"832768","DOI":"10.3389\/fnagi.2022.832768","volume":"14","author":"Z Chang","year":"2022","unstructured":"Chang, Z. et al. Retinal nerve fiber layer thickness and associations with cognitive impairment in Parkinson\u2019s disease. Front. Aging Neurosci. 14, 832768 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"611_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London, A., Benhar, I. & Schwartz, M. The retina as a window to the brain-from eye research to CNS disorders. Nat. Rev. Neurol. 9, 44\u201353 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"611_CR27","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n, I. et al. Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov. Disord. 33, 1315\u20131324 (2018).","journal-title":"Mov. Disord."},{"key":"611_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","volume":"137","author":"L Veys","year":"2019","unstructured":"Veys, L. et al. Retinal \u03b1-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta. Neuropathol. 137, 379\u2013395 (2019).","journal-title":"Acta. Neuropathol."},{"key":"611_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1126\/science.1069609","volume":"295","author":"S Hattar","year":"2002","unstructured":"Hattar, S., Liao, H. W., Takao, M., Berson, D. M. & Yau, K. W. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295, 1065\u20131070 (2002).","journal-title":"Science"},{"key":"611_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-018-0596-z","volume":"6","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n, I. et al. Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson\u2019s disease. Acta. Neuropathol. Commun. 6, 90 (2018).","journal-title":"Acta. Neuropathol. Commun."},{"key":"611_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fneur.2017.00162","volume":"8","author":"C La Morgia","year":"2017","unstructured":"La Morgia, C., Ross-Cisneros, F. N., Sadun, A. A. & Carelli, V. Retinal ganglion cells and circadian rhythms in Alzheimer\u2019s disease, Parkinson\u2019s disease, and beyond. Front. Neurol. 8, 162 (2017).","journal-title":"Front. Neurol."},{"key":"611_CR32","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u201398 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"611_CR33","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. Bmj 362, k601 (2018).","journal-title":"Bmj"},{"key":"611_CR34","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/mds.28765","volume":"36","author":"Z Gan-Or","year":"2021","unstructured":"Gan-Or, Z. & Wood, N. W. Mendelian randomization studies: a path to better understand sex and gender differences in Parkinson\u2019s disease? Mov. Disord. 36, 2220\u20132222 (2021).","journal-title":"Mov. Disord."},{"key":"611_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26280-1","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm, C. S. et al. Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat. Commun. 12, 7342 (2021).","journal-title":"Nat. Commun."},{"key":"611_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"611_CR37","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1002\/mds.27845","volume":"34","author":"H Iwaki","year":"2019","unstructured":"Iwaki, H. et al. Genomewide association study of Parkinson\u2019s disease clinical biomarkers in 12 longitudinal patients\u2019 cohorts. Mov. Disord. 34, 1839\u20131850 (2019).","journal-title":"Mov. Disord."},{"key":"611_CR38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/mds.27659","volume":"34","author":"C Blauwendraat","year":"2019","unstructured":"Blauwendraat, C. et al. Parkinson\u2019s disease age at onset genome-wide association study: defining heritability, genetic loci, and \u03b1-synuclein mechanisms. Mov. Disord. 34, 866\u2013875 (2019).","journal-title":"Mov. Disord."},{"key":"611_CR39","doi-asserted-by":"publisher","first-page":"e1009497","DOI":"10.1371\/journal.pgen.1009497","volume":"17","author":"H Currant","year":"2021","unstructured":"Currant, H. et al. Genetic variation affects morphological retinal phenotypes extracted from UK Biobank optical coherence tomography images. PLoS Genet. 17, e1009497 (2021).","journal-title":"PLoS Genet."},{"key":"611_CR40","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. Bmj 375, n2233 (2021).","journal-title":"Bmj"},{"key":"611_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48388-7","volume":"9","author":"MS Sung","year":"2019","unstructured":"Sung, M. S. et al. Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson\u2019s disease. Sci. Rep. 9, 11832 (2019).","journal-title":"Sci. Rep."},{"key":"611_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.27914","volume":"35","author":"JY Lee","year":"2020","unstructured":"Lee, J. Y. et al. Retina thickness as a marker of neurodegeneration in prodromal lewy body disease. Mov. Disord. 35, 349\u2013354 (2020).","journal-title":"Mov. Disord."},{"key":"611_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/bs.irn.2017.06.003","volume":"134","author":"F Stocchi","year":"2017","unstructured":"Stocchi, F. & Torti, M. Constipation in Parkinson\u2019s disease. Int. Rev. Neurobiol. 134, 811\u2013826 (2017).","journal-title":"Int. Rev. Neurobiol."},{"key":"611_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41531-021-00191-w","volume":"7","author":"M Camacho","year":"2021","unstructured":"Camacho, M. et al. Early constipation predicts faster dementia onset in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 7, 45 (2021).","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"611_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00002826-199210000-00004","volume":"15","author":"R Astarloa","year":"1992","unstructured":"Astarloa, R., Mena, M. A., S\u00e1nchez, V., de la Vega, L. & de Y\u00e9benes, J. G. Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease. Clin. Neuropharmacol. 15, 375\u2013380 (1992).","journal-title":"Clin. Neuropharmacol."},{"key":"611_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/jgs.13279","volume":"63","author":"R Sakakibara","year":"2015","unstructured":"Sakakibara, R. et al. Nizatidine ameliorates slow transit constipation in Parkinson\u2019s disease. J. Am. Geriatr. Soc. 63, 399\u2013401 (2015).","journal-title":"J. Am. Geriatr. Soc."},{"key":"611_CR47","doi-asserted-by":"publisher","first-page":"928980","DOI":"10.3389\/fnins.2022.928980","volume":"16","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Ophthalmologic problems correlates with cognitive impairment in patients with Parkinson\u2019s disease. Front. Neurosci. 16, 928980 (2022).","journal-title":"Front. Neurosci."},{"key":"611_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MCG.0000000000001333","volume":"54","author":"H Duboc","year":"2020","unstructured":"Duboc, H., Coffin, B. & Siproudhis, L. Disruption of circadian rhythms and gut motility: an overview of underlying mechanisms and associated pathologies. J. Clin. Gastroenterol. 54, 405\u2013414 (2020).","journal-title":"J. Clin. Gastroenterol."},{"key":"611_CR49","doi-asserted-by":"publisher","first-page":"G549","DOI":"10.1152\/ajpgi.00147.2010","volume":"299","author":"WA Hoogerwerf","year":"2010","unstructured":"Hoogerwerf, W. A. Role of clock genes in gastrointestinal motility. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G549\u2013555 (2010).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"611_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","volume":"15","author":"C Cajochen","year":"2003","unstructured":"Cajochen, C., Kr\u00e4uchi, K. & Wirz-Justice, A. Role of melatonin in the regulation of human circadian rhythms and sleep. J. Neuroendocrinol. 15, 432\u2013437 (2003).","journal-title":"J. Neuroendocrinol."},{"key":"611_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-079X.1989.tb00909.x","volume":"7","author":"GA Bubenik","year":"1989","unstructured":"Bubenik, G. A. & Dhanvantari, S. Influence of serotonin and melatonin on some parameters of gastrointestinal activity. J. Pineal. Res. 7, 333\u2013344 (1989).","journal-title":"J. Pineal. Res."},{"key":"611_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","volume":"62","author":"M Simr\u00e9n","year":"2013","unstructured":"Simr\u00e9n, M. et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62, 159\u2013176 (2013).","journal-title":"Gut"},{"key":"611_CR53","doi-asserted-by":"publisher","unstructured":"Vich Vila, A. et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aap8914 (2018).","DOI":"10.1126\/scitranslmed.aap8914"},{"key":"611_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/bs.irn.2016.07.002","volume":"131","author":"RM Voigt","year":"2016","unstructured":"Voigt, R. M., Forsyth, C. B., Green, S. J., Engen, P. A. & Keshavarzian, A. Circadian rhythm and the gut microbiome. Int. Rev. Neurobiol. 131, 193\u2013205 (2016).","journal-title":"Int. Rev. Neurobiol."},{"key":"611_CR55","doi-asserted-by":"publisher","unstructured":"Iesanu, M. I. et al. Melatonin-microbiome two-sided interaction in dysbiosis-associated conditions. Antioxid. Basel https:\/\/doi.org\/10.3390\/antiox11112244 (2022).","DOI":"10.3390\/antiox11112244"},{"key":"611_CR56","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s10792-021-02190-5","volume":"42","author":"H Gong","year":"2022","unstructured":"Gong, H. et al. The profile of gut microbiota and central carbon-related metabolites in primary angle-closure glaucoma patients. Int. Ophthalmol. 42, 1927\u20131938 (2022).","journal-title":"Int. Ophthalmol."},{"key":"611_CR57","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s11325-016-1366-4","volume":"20","author":"ZJ Yang","year":"2016","unstructured":"Yang, Z. J. et al. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson\u2019s disease. Sleep. Breath. 20, 1285\u20131292 (2016).","journal-title":"Sleep. Breath."},{"key":"611_CR58","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1176\/appi.neurospych.17030063","volume":"30","author":"DK Li","year":"2018","unstructured":"Li, D. K. et al. Depressive symptoms are associated with color vision but not Olfactory function in patients with Parkinson\u2019s disease. J. Neuropsychiat. Clin. Neurosci. 30, 122\u2013129 (2018).","journal-title":"J. Neuropsychiat. Clin. Neurosci."},{"key":"611_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jad.2016.06.039","volume":"204","author":"A Kalenderoglu","year":"2016","unstructured":"Kalenderoglu, A., \u00c7elik, M., Sevgi-Karadag, A. & Egilmez, O. B. Optic coherence tomography shows inflammation and degeneration in major depressive disorder patients correlated with disease severity. J. Affect Disord. 204, 159\u2013165 (2016).","journal-title":"J. Affect Disord."},{"key":"611_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/ana.25944","volume":"89","author":"A Murueta-Goyena","year":"2021","unstructured":"Murueta-Goyena, A. et al. Retinal thickness predicts the risk of cognitive decline in Parkinson disease. Ann. Neurol. 89, 165\u2013176 (2021).","journal-title":"Ann. Neurol."},{"key":"611_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-022-01714-2","volume":"22","author":"G Yang","year":"2023","unstructured":"Yang, G. & Schooling, C. M. Investigating sex-specific associations of lipid traits with type 2 diabetes, glycemic traits and sex hormones using Mendelian randomization. Cardiovasc. Diabetol. 22, 3 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"611_CR62","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/art.41561","volume":"73","author":"S Luo","year":"2021","unstructured":"Luo, S. et al. Platelet glycoprotein Ib \u03b1-Chain as a putative therapeutic target for juvenile idiopathic Arthritis: a Mendelian randomization study. Arthrit. Rheumatol. 73, 693\u2013701 (2021).","journal-title":"Arthrit. Rheumatol."},{"key":"611_CR63","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/ije\/dyab084","volume":"50","author":"C Minelli","year":"2021","unstructured":"Minelli, C. et al. The use of two-sample methods for Mendelian randomization analyses on single large datasets. Int. J. Epidemiol. 50, 1651\u20131659 (2021).","journal-title":"Int. J. Epidemiol."},{"key":"611_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0962280210394459","volume":"21","author":"TM Palmer","year":"2012","unstructured":"Palmer, T. M. et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat. Methods Med Res 21, 223\u2013242 (2012).","journal-title":"Stat. Methods Med Res"},{"key":"611_CR65","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor, D. A., Harbord, R. M., Sterne, J. A., Timpson, N. & Davey Smith, G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat. Med. 27, 1133\u20131163 (2008).","journal-title":"Stat. Med."},{"key":"611_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/321275","volume":"69","author":"JK Pritchard","year":"2001","unstructured":"Pritchard, J. K. & Przeworski, M. Linkage disequilibrium in humans: models and data. Am. J. Hum. Genet. 69, 1\u201314 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"611_CR67","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, e34408 (2018).","journal-title":"Elife"},{"key":"611_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56\u201365 (2012).","journal-title":"Nature"},{"key":"611_CR69","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081 (2017).","journal-title":"PLoS Genet."},{"key":"611_CR70","doi-asserted-by":"publisher","unstructured":"Elsworth, B. et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv https:\/\/doi.org\/10.1101\/2020.08.10.244293 (2020).","DOI":"10.1101\/2020.08.10.244293"},{"key":"611_CR71","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3945\/ajcn.115.118216","volume":"103","author":"PC Haycock","year":"2016","unstructured":"Haycock, P. C. et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am. J. Clin. Nutr. 103, 965\u2013978 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"611_CR72","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck, M., Chen, C. Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 50, 693\u2013698 (2018).","journal-title":"Nat. Genet."},{"key":"611_CR73","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48","author":"J Bowden","year":"2019","unstructured":"Bowden, J. et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int. J. Epidemiol. 48, 728\u2013742 (2019).","journal-title":"Int. J. Epidemiol."},{"key":"611_CR74","doi-asserted-by":"publisher","first-page":"782476","DOI":"10.3389\/fgene.2022.782476","volume":"13","author":"D Zhu","year":"2022","unstructured":"Zhu, D. et al. Total brain volumetric measures and Schizophrenia risk: a two-sample Mendelian randomization study. Front. Genet. 13, 782476 (2022).","journal-title":"Front. Genet."},{"key":"611_CR75","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess, S. et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 4, 186 (2019).","journal-title":"Wellcome Open Res."},{"key":"611_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1716-1","volume":"20","author":"K Korthauer","year":"2019","unstructured":"Korthauer, K. et al. A practical guide to methods controlling false discoveries in computational biology. Genom. Biol. 20, 118 (2019).","journal-title":"Genom. Biol."},{"key":"611_CR77","doi-asserted-by":"crossref","unstructured":"Hemani, G. et al. Automating Mendelian randomization through machine learning to construct a putative causal map of the human phenome. bioRxiv 18, 173682 (2017).","DOI":"10.1101\/173682"},{"key":"611_CR78","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob, E. A. W. & Burgess, S. A comparison of robust Mendelian randomization methods using summary data. Genet. Epidemiol. 44, 313\u2013329 (2020).","journal-title":"Genet. Epidemiol."},{"key":"611_CR79","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression. Int. J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"611_CR80","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/ije\/dyw252","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int. J. Epidemiol. 45, 1961\u20131974 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"611_CR81","doi-asserted-by":"publisher","first-page":"e1954","DOI":"10.1210\/clinem\/dgac008","volume":"107","author":"X Qi","year":"2022","unstructured":"Qi, X., Cui, B. & Cao, M. The role of morning plasma cortisol in obesity: a bidirectional Mendelian randomization study. J. Clin. Endocrinol. Metab. 107, e1954\u2013e1960 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"611_CR82","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1214\/19-AOS1866","volume":"48","author":"Q Zhao","year":"2020","unstructured":"Zhao, Q., Wang, J., Hemani, G., Bowden, J. & Small, D. S. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. The. Ann. Stat. 48, 1742\u20131769 (2020).","journal-title":"Ann. Stat."},{"key":"611_CR83","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet. Epidemiol."},{"key":"611_CR84","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig, F. P., Davey Smith, G. & Bowden, J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J. Epidemiol. 46, 1985\u20131998 (2017).","journal-title":"Int J. Epidemiol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00611-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00611-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T15:04:37Z","timestamp":1702479877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00611-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00611-z","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"25 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"163"}}